Home » Foresite Capital

Skip to content

FinSMEs

REAL TIME VC & PRIVATE EQUITY DEALS AND NEWS

Search for:

Facebook
Twitter
Linkedin

Navigation

Site navigation

USA
UK
Germany
Canada
China
Russia
India
France
Italy
NFT

Home
Foresite Capital

Foresite Capital

Foresight Diagnostics

USA

Foresight Diagnostics Raises $58.75M in Series B Financing

Published on April 27, 2023April 27, 2023By FinSMEs

cerevance

USA

Cerevance Expands Series B Financing with Additional $51M

Published on February 13, 2023February 13, 2023By FinSMEs

Evonetix

UK

Evonetix Raises Additional $24M in Series B Funding

Published on February 8, 2023February 8, 2023By FinSMEs

Odyssey Therapeutics

USA

Odyssey Therapeutics Raises $168M in Series B Financing

Published on October 13, 2022October 13, 2022By FinSMEs

Pleno

USA

Pleno Raises $40M in Series A Funding

Published on October 12, 2022October 12, 2022By FinSMEs

FOLX Health

USA

Folx Health Raises $30M in Series B Funding

Published on October 12, 2022October 12, 2022By FinSMEs

Delfi Diagnostics Announces $225 Million Series B Financing

USA

Delfi Diagnostics Raises $225M in Series B Financing

Published on July 18, 2022July 18, 2022By FinSMEs

USA

Remix Therapeutics Raises $70 Million in Series B Financing

Published on May 18, 2022May 18, 2022By FinSMEs

USA

Kriya Therapeutics Raises $270M in Series C Financing

Published on May 17, 2022May 17, 2022By FinSMEs

Mirvie

USA

Mirvie Raises $60M in Series B Funding

Published on May 17, 2022May 18, 2022By FinSMEs

dnanexus

USA

DNAnexus Secures $200M in Funding

Published on March 8, 2022March 8, 2022By FinSMEs

Foresite-Capital-Managing-Directors

USA

Foresite Capital Raises $173M to Fund Foresite Labs Incubated Life Science Companies

Published on March 4, 2022March 4, 2022By FinSMEs

Sumant Ramachandra

USA

ImmPACT Bio Closes $111M Series B Financing

Published on January 21, 2022January 21, 2022By FinSMEs

healthcare

USA

Odyssey Therapeutics Raises $218M in Series A Financing

Published on December 8, 2021December 8, 2021By FinSMEs

Element Biosciences

USA

Element Biosciences Raises $276M in Series C Financing

Published on July 1, 2021July 1, 2021By FinSMEs

Posts navigation

← Older posts

The Daily Deal Newsletter – Sign Up

Email address:

Leave this field empty if you're human:

About | Advertise | Contact | Terms & Conditions | Disclaimer | News | The Daily Deal Newsletter

Privacy Policy FinSMEs is owned by FinSMEs Ltd - 86 - 90 Paul Street - London, UK - EC2A 4NE - e-mail: [email protected]

Follow FinSMEs on:

Sign-up now to the Daily Newsletter